002750 Stock Overview
Kunming Longjin Pharmaceutical Co., Ltd. therapeutic medicines for people living with cardiovascular, cerebrovascular, and metabolic diseases in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Kunming Longjin Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥2.56 |
| 52 Week High | CN¥12.00 |
| 52 Week Low | CN¥1.43 |
| Beta | 0.38 |
| 11 Month Change | 23.08% |
| 3 Month Change | 25.49% |
| 1 Year Change | -77.66% |
| 33 Year Change | -64.59% |
| 5 Year Change | -80.19% |
| Change since IPO | -49.71% |
Recent News & Updates
What Kunming Longjin Pharmaceutical Co., Ltd.'s (SZSE:002750) 38% Share Price Gain Is Not Telling You
Aug 14
Kunming Longjin Pharmaceutical Co., Ltd. (SZSE:002750) May Have Run Too Fast Too Soon With Recent 40% Price Plummet
Jun 30Recent updates
What Kunming Longjin Pharmaceutical Co., Ltd.'s (SZSE:002750) 38% Share Price Gain Is Not Telling You
Aug 14Kunming Longjin Pharmaceutical Co., Ltd. (SZSE:002750) May Have Run Too Fast Too Soon With Recent 40% Price Plummet
Jun 30Risks Still Elevated At These Prices As Kunming Longjin Pharmaceutical Co., Ltd. (SZSE:002750) Shares Dive 26%
Apr 26We're Not Very Worried About Kunming Longjin Pharmaceutical's (SZSE:002750) Cash Burn Rate
Apr 17Revenues Not Telling The Story For Kunming Longjin Pharmaceutical Co., Ltd. (SZSE:002750) After Shares Rise 29%
Mar 08Shareholder Returns
| 002750 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -14.4% | -1.3% | -3.4% |
| 1Y | -77.7% | -3.4% | 6.1% |
Return vs Industry: 002750 underperformed the CN Pharmaceuticals industry which returned -3.4% over the past year.
Return vs Market: 002750 underperformed the CN Market which returned 6.1% over the past year.
Price Volatility
| 002750 volatility | |
|---|---|
| 002750 Average Weekly Movement | 8.3% |
| Pharmaceuticals Industry Average Movement | 7.2% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.5% |
Stable Share Price: 002750 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002750's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 285 | Lijuan Fan | www.longjin.com.cn |
Kunming Longjin Pharmaceutical Co., Ltd. therapeutic medicines for people living with cardiovascular, cerebrovascular, and metabolic diseases in China. The company offers medicines in the areas of cardiovascular and cerebrovascular, digestive system, vitamin, minerals and enteral nutrition, and immunology, as well as first aid kits; extracts of natural plants, such as breviscapine; and industrial hemp consumer products. It also engages in the industrial hemp plantation business.
Kunming Longjin Pharmaceutical Co., Ltd. Fundamentals Summary
| 002750 fundamental statistics | |
|---|---|
| Market cap | CN¥1.03b |
| Earnings (TTM) | -CN¥53.63m |
| Revenue (TTM) | CN¥62.17m |
16.5x
P/S Ratio-19.1x
P/E RatioIs 002750 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002750 income statement (TTM) | |
|---|---|
| Revenue | CN¥62.17m |
| Cost of Revenue | CN¥30.06m |
| Gross Profit | CN¥32.12m |
| Other Expenses | CN¥85.75m |
| Earnings | -CN¥53.63m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.13 |
| Gross Margin | 51.66% |
| Net Profit Margin | -86.26% |
| Debt/Equity Ratio | 0.2% |
How did 002750 perform over the long term?
See historical performance and comparison